A high-level overview of Stem, Inc. (STEM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
DateTypeShareholderTitleTransaction TypeShare PriceSharesValue May 1, 2023SalePrakesh PatelChief Strategy OfficerDisposition$4.12 PER SHARE-1,260$-5,191 Apr 28, 2023PurchasePrakesh PatelChief Strategy OfficerDerivative/Non-derivative$0.00 PER SHARE3,453$0 ...
DateTypeShareholderTitleTransaction TypeShare PriceSharesValue May 1, 2023SaleSaul R. LaurelesChief Legal OfficerDisposition$4.12 PER SHARE-887$-3,654 Apr 28, 2023PurchaseSaul R. LaurelesChief Legal OfficerDerivative/Non-derivative$0.00 PER SHARE3,453$0 ...
Britannic Reassurance Fails to Stem Slide in Share PriceTHE BRITANNIC Group moved to stem the downward spiral in itsshare price, which at one point...Stevenson, Rachel
Verastem Inc. reported a loss of $8.3 million in the second quarter, with a loss of 31 cents per share, exceeding Wall Street expectations. The company posted revenue of $10 million. The reported financial results are moderately noticeable and may affect the company's financial performance and...
Verastem, Inc. price and volume Combination chart with 2 data series. Chart represents Verastem, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displaying symbol price, and symbol volume.. Feb 2025Dec 2024Oct 2024Aug 2024...
Thermo Fisher Scientific Inc., Takara Bio Inc, Merck KGaA, BD, STEMCELL Technologies., AllCells LLC, Miltenyi Biotec, International Stem Cell Corporation, ReNeuron Group PLC, Bio-Techn. Many companies in the stem cell market enter into partnerships with academic institutions or other biotechnology co...
Most of Stem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stem Inc is consi...
Price Target $13.38 Consensus Rating Buy Company Overview Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, an orally available small molecule RAF/MEK...
Q6. Which are the top companies hold the market share in Stem cell banking market? Q7. What are the market values / growth % of emerging countries? Q8. What are the key trends in the stem cell banking market report? Table Of Content Chapter 1 : INTRODUCTION Chapter 2 : EXECUTIVE...